Bill Ackman
Pershing Square Capital Management
Pershing Square Capital Management Portfolio 13F
Bill Ackman Holdings Activity
- Portfolio value:
- $12.46B≈ (-$1B≈)
- Previous value:
- $13.95B≈
- # of changes:
- 1
- New positions:
- 0
- Reported for:
- 31 Dec 2015 (Q4)
- Latest filing date:
- 16 Feb 2016
Pershing Square Capital Management has disclosed a total of 1 change to the portfolio in the (2015 Q4) SEC report(s): decreased the number of shares of 1 position(s).
What stocks did Bill Ackman buy in 2015 Q4?
During 2015 Q4 Bill Ackman has not purchased any securities.
What did Bill Ackman invest in during 2015 Q4?
In the 2015 Q4 report(s) the following change has been made to the top investments: (VRX) Valeant Pharmaceuticals International Inc (reduced shares -14.80%).
Warning: SEC insider reports detected for Pershing Square Capital Management (real-time trades and ownership disclosures)
6 transactions as of 1 month ago and 10 ownership disclosures as of 1 month ago
1 result
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Valeant Pharmaceuticals International Inc
|
-14.80%
|
$101.65
|
|
13.54%
|
2015 Q1
|
≈ 1.00 year
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.